Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |